Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fesoterodine fumarate for neurogenic bladder
ISRCTN22433402Phase 4Completed
- Sponsor
- National Rehabilitation Center
- Start
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of fesoterodine in detrusor hyperreflexia (DH), sponsored by National Rehabilitation Center. Primary endpoints: Bladder function by urodynamics testing, Three-day bladder diary and 1 more. Started Dec 2015; status: completed.
02
Drugs
fesoterodine
03
Conditions
detrusor hyperreflexia (DH)
Beyond the preview
Go deeper on ISRCTN22433402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN22433402.